PROCAPS GROUP SA (PROC)
LU2376511205 - Common Stock
Procaps Issues Shareholder Letter Update
Procaps Issues Shareholder Letter Update
MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading...
Procaps Issues Shareholder Letter
Procaps Issues Shareholder Letter
MIAMI and BARRANQUILLA, Colombia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading...
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.
Procaps Group Announces New Chairman
Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F
Procaps Group Delays Filing of Annual Report on Form 20-F
Procaps Group Delays Filing of Annual Report on Form 20-F
Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives
Procaps Issues Shareholder Letter from New CEO
Procaps Group – Notice to Shareholders
Procaps Group reports Q3 results; updates FY23 outlook (NASDAQ:PROC)
Procaps Group press release (PROC): Q3 Adjusted EBITDA was $22 million in 3Q23, with an Adjusted EBITDA margin of 19%. Revenue of $118M (+7.3% Y/Y) beats by $7.4M.
PROC Stock Earnings: Procaps Gr Beats EPS, Beats Revenue for Q3 2023
PROC stock results show that Procaps Gr beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023.
PROC Stock Earnings: Procaps Gr Beats EPS, Beats Revenue for Q3 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Procaps Gr (NASDAQ:PROC) just reported results for the third quarter of 2023.Pr...
Procaps Group Reports Third Quarter 2023 Results
Statement from the Board of Directors of Procaps Group
Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America
/PRNewswire/ -- Procaps Group (NASDAQ: PROC) ("Procaps"), a leading integrated international healthcare and pharmaceutical services company, and Genomma Lab...
Procaps Group says CEO Minski to step down from the role (NASDAQ:PROC)
Procaps Group announces CEO transition as Ruben Minski steps down after 45 years.
Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024
Procaps Group Update on Third Quarter Results
Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023
Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia
Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors
Procaps Group to Participate at CPHI Barcelona 2023
